Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Panitumumab in Combination With Irinotecan for Malignant Gliomas

NCT01017653 is registered in ClinicalTrials.gov with Annick Desjardins as lead sponsor.

NCT NCT01017653
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01017653 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Panitumumab in Combination With Irinotecan for Malignant Gliomas
Lead sponsor
Annick Desjardins
Phase
Phase 2
Overall status
Terminated
Start date
February 28, 2010
Completion date
October 31, 2011
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malignant glioma of brain